project id: TCGA-OV; case submitter id: TCGA-13-2071; selected normal wgs: true; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.5; spectrophotometer method: UV Spec; age at index: 63; days to birth: -23367; days to death: 773; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1946; age at diagnosis: 23367; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 191.0; figo stage: Stage IV; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 2.0; longest dimension: 2.5; preservation method: Unknown; shortest dimension: 0.6; sample id: d9a5b17a-298e-4836-a3f3-d2385f3c0936; sample submitter id: TCGA-13-2071-01A; portion id: 1f463b3f-64a3-412b-a61d-8bc90691e60b; portion submitter id: TCGA-13-2071-01A-02; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent tumor nuclei: 85.0;